306 related articles for article (PubMed ID: 28929962)
1. [Determination of in vitro susceptibilities of Brucella spp. strains against 11 different antibacterial gents isolated from blood cultures].
Keşli R; Bilgin H; Yılmaz H
Mikrobiyol Bul; 2017 Jul; 51(3):260-268. PubMed ID: 28929962
[TBL] [Abstract][Full Text] [Related]
2. Identification and determination of antibiotic susceptibilities of Brucella strains isolated from patients in van, Turkey by conventional and molecular methods.
Parlak M; Güdücüoğlu H; Bayram Y; Çıkman A; Aypak C; Kılıç S; Berktaş M
Int J Med Sci; 2013; 10(10):1406-11. PubMed ID: 23983603
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis.
Kilic S; Dizbay M; Cabadak H
J Chemother; 2008 Feb; 20(1):33-7. PubMed ID: 18390405
[TBL] [Abstract][Full Text] [Related]
4. [Short communication: Investigation of in vitro antibiotic susceptibility of Brucella melitensis].
Alişkan H; Turunç T; Demiroğlu YZ; Colakoğlu S; Arslan H
Mikrobiyol Bul; 2008 Jan; 42(1):125-9. PubMed ID: 18444570
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.
Bayram Y; Korkoca H; Aypak C; Parlak M; Cikman A; Kilic S; Berktas M
Int J Med Sci; 2011 Mar; 8(3):198-202. PubMed ID: 21448305
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of in vitro activities of tigecycline and various antibiotics against Brucella spp.
Ozhak-Baysan B; Ongut G; Ogunc D; Gunseren F; Sepin-Ozen N; Ozturk F; Aktepe OC; Gultekin M
Pol J Microbiol; 2010; 59(1):55-60. PubMed ID: 20568531
[TBL] [Abstract][Full Text] [Related]
7. Biotypes and antimicrobial susceptibilities of Brucella isolates.
Bodur H; Balaban N; Aksaray S; Yetener V; Akinci E; Colpan A; Erbay A
Scand J Infect Dis; 2003; 35(5):337-8. PubMed ID: 12875523
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility testing of Brucella melitensis isolated from patients with acute brucellosis in a centre of Iran.
Razzaghi R; Rastegar R; Momen-Heravi M; Erami M; Nazeri M
Indian J Med Microbiol; 2016; 34(3):342-5. PubMed ID: 27514957
[TBL] [Abstract][Full Text] [Related]
10. Investigation of antibiotic susceptibilities of Brucella Strains isolated from various clinical samples in eastern Turkey.
Gültekin E; Uyanık MH; Albayrak A; Kılıç S
Eur J Med Res; 2021 Jun; 26(1):57. PubMed ID: 34134763
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean region in Turkey.
Yamazhan T; Aydemir S; Tünger A; Serter D; Gökengin D
Med Princ Pract; 2005; 14(6):413-6. PubMed ID: 16220015
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiological and microbiological study of brucellosis in Kuwait.
Dimitrov Ts; Panigrahi D; Emara M; Awni F; Passadilla R
Med Princ Pract; 2004; 13(4):215-9. PubMed ID: 15181327
[TBL] [Abstract][Full Text] [Related]
13. In vitro antimicrobial susceptibility of Brucella species.
Baykam N; Esener H; Ergönül O; Eren S; Celikbas AK; Dokuzoguz B
Int J Antimicrob Agents; 2004 Apr; 23(4):405-7. PubMed ID: 15081093
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.
López-Merino A; Contreras-Rodríguez A; Migranas-Ortiz R; Orrantia-Gradín R; Hernández-Oliva GM; Gutiérrez-Rubio AT; Cardeñosa O
Scand J Infect Dis; 2004; 36(9):636-8. PubMed ID: 15370648
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis.
Bosch J; Liñares J; López de Goicoechea MJ; Ariza J; Cisnal MC; Martin R
J Antimicrob Chemother; 1986 Apr; 17(4):459-61. PubMed ID: 2940209
[TBL] [Abstract][Full Text] [Related]
16. [E-test susceptibility results of brucella strains for streptomycin, rifampicin, ciprofloxacin and tetracycline].
Sengöz G; Yaşar KK; Kutlu SB; Durdu YB; Ozdemir R; Nazlican O
Mikrobiyol Bul; 2006 Jul; 40(3):265-8. PubMed ID: 17001857
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics.
Turkmani A; Ioannidis A; Christidou A; Psaroulaki A; Loukaides F; Tselentis Y
Ann Clin Microbiol Antimicrob; 2006 Oct; 5():24. PubMed ID: 17014707
[TBL] [Abstract][Full Text] [Related]
18. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.
Deshmukh A; Hagen F; Sharabasi OA; Abraham M; Wilson G; Doiphode S; Maslamani MA; Meis JF
BMC Microbiol; 2015 Jun; 15():121. PubMed ID: 26073177
[TBL] [Abstract][Full Text] [Related]
19. The canonical Brucella species-host dependency is changing, however, the antibiotic susceptibility profiles remain unchanged.
Celik E; Kayman T; Buyuk F; Gulmez Saglam A; Abay S; Akar M; Karakaya E; Balkan Bozlak CE; Coskun MR; Buyuk E; Celebi O; Sahin M; Saticioglu IB; Durhan S; Baykal A; Ersoy Y; Otlu S; Aydin F
Microb Pathog; 2023 Sep; 182():106261. PubMed ID: 37488036
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance.
Abdel-Maksoud M; House B; Wasfy M; Abdel-Rahman B; Pimentel G; Roushdy G; Dueger E
Ann Clin Microbiol Antimicrob; 2012 Aug; 11():24. PubMed ID: 22929054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
